Robert C. Murphy, Anne Messer  Molecular Therapy 

Slides:



Advertisements
Similar presentations
Transfection.
Advertisements

Molecular Therapy - Nucleic Acids
Léa L Lesueur, Lluis M Mir, Franck M André 
Volume 2, Issue 4, Pages (October 2000)
Volume 8, Issue 2, Pages (August 2003)
L. Pesesse, C. Sanchez, D. A. Walsh, J. -P. Delcour, C. Baudouin, P
Volume 6, Issue 5, Pages (November 2002)
Volume 123, Issue 1, Pages (July 2002)
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Volume 4, Issue 2, Pages (August 2001)
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Volume 10, Issue 4, Pages (October 2004)
Volume 6, Issue 3, Pages (September 2002)
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Transgene Expression in the Brain Stem Effected by Intramuscular Injection of Polyethylenimine/DNA Complexes  Shu Wang, Nan Ma, Shujun J. Gao, Hanry Yu,
Volume 13, Issue 1, Pages (January 2006)
Myoblast Transplantation for Cardiac Repair: A Clinical Perspective
M.Brandon Parrott, Michael A. Barry  Molecular Therapy 
Development of Peptide-targeted Lipoplexes to CXCR4-expressing Rat Glioma Cells and Rat Proliferating Endothelial Cells  Wouter HP Driessen, Nobutaka.
Volume 6, Issue 5, Pages (November 2002)
Volume 9, Issue 3, Pages (March 2004)
Molecular Therapy - Nucleic Acids
Léa L Lesueur, Lluis M Mir, Franck M André 
Volume 14, Issue 3, Pages (September 2006)
Generation of a Flexible Cell Line with Regulatable, High-Level Expression of HIV Gag/Pol Particles Capable of Packaging HIV-Derived Vectors  Sandra Sparacio,
VSV-G Envelope Glycoprotein Forms Complexes with Plasmid DNA and MLV Retrovirus-like Particles in Cell-free Conditions and Enhances DNA Transfection 
Imaging Transgene Expression in Live Animals
Daniel G. Anderson, Akin Akinc, Naushad Hossain, Robert Langer 
Topical N-acetyl-S-farnesyl-L-cysteine Inhibits Mouse Skin Inflammation, and Unlike Dexamethasone, its Effects Are Restricted to the Application Site 
Molecular Therapy  Volume 20, (May 2012) DOI: /S (16)
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Volume 8, Issue 1, Pages (July 2003)
Kailin Xu, Hong Ma, Thomas J. McCown, Inder M. Verma, Tal Kafri 
847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach    Molecular.
Designer Lipids Advance Systemic siRNA Delivery
133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular.
J.P O'Rourke, H Hiraragi, K Urban, M Patel, J.C Olsen, B.A Bunnell 
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
Rapid and Slow Voltage-Dependent Conformational Changes in Segment IVS6 of Voltage-Gated Na+ Channels  Vasanth Vedantham, Stephen C. Cannon  Biophysical.
68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI)    Molecular.
521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies    Molecular Therapy  Volume 22, Pages.
Thomas S. Griffith, Elizabeth L. Broghammer  Molecular Therapy 
Molecular Therapy - Nucleic Acids
Volume 55, Issue 5, Pages (May 1999)
Nerve Growth Factor Receptor-Mediated Gene Transfer
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
Plasmid Delivery in Vivo from Porous Tissue-Engineering Scaffolds: Transgene Expression and Cellular Transfection  Jae-Hyung Jang, Christopher B. Rives,
Transcriptional Pulsing of a Developmental Gene
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Daniel G. Anderson, Akin Akinc, Naushad Hossain, Robert Langer 
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Volume 8, Issue 2, Pages (August 2003)
Volume 26, Issue 2, Pages (February 2018)
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS  Brad E. Hoffman  Molecular.
Volume 3, Issue 3, Pages (March 2001)
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy    Molecular Therapy  Volume 20, Pages S35-S36.
Single-Cell Electroporationfor Gene Transfer In Vivo
Volume 4, Issue 4, Pages (October 2001)
Tatiana Zavorotinskaya, Adrian Tomkinson, John E Murphy 
Volume 4, Issue 2, Pages (August 2001)
Transcriptional Pulsing of a Developmental Gene
Volume 11, Issue 1, Pages (January 2005)
Volume 3, Issue 1, Pages 8-13 (January 2001)
Arati Sridharan, Chetan Patel, Jit Muthuswamy 
Volume 2, Issue 3, Pages (September 2000)
Presentation transcript:

Gene Transfer Methods for CNS Organotypic Cultures: A Comparison of Three Nonviral Methods  Robert C. Murphy, Anne Messer  Molecular Therapy  Volume 3, Issue 1, Pages 113-121 (January 2001) DOI: 10.1006/mthe.2000.0235 Copyright © 2001 American Society for Gene Therapy Terms and Conditions

FIG. 1 Immunohistochemical preparation of organotypic cerebellar slices after culturing for 24 h. Purkinje cells are labeled by a monoclonal antibody against calbindin-D-28K, a cell-specific marker. Density and morphology are maintained. Molecular Therapy 2001 3, 113-121DOI: (10.1006/mthe.2000.0235) Copyright © 2001 American Society for Gene Therapy Terms and Conditions

FIG. 2 Effect of voltage (V) and length (ms) of each pulse, the interval (s) between, and the total number of pulses on gene transfer into cerebellar slices by electroporation. The y axes are the numbers of transfers normalized to baseline conditions, 6 pulses at 100 V, 50 ms in length, with a 1-s interval. (A) Alteration of voltage over a range from 50 to 400 V, all other parameters kept at the baseline conditions. (B) Length of the pulse was altered over a range from 12 to 200 ms, all other parameters kept at the baseline conditions. (C) The effect of the interval between pulses over a range of 0.1 to 10 s, all other parameters kept at the baseline conditions. (D) Total number of pulses over a range of 3 to 48. Each data point contains a minimum of N = 4. Molecular Therapy 2001 3, 113-121DOI: (10.1006/mthe.2000.0235) Copyright © 2001 American Society for Gene Therapy Terms and Conditions

FIG. 3 Effects of concentration and volume on gene transfer. (A) 1.0–10 μl of 1.8 μg/μl pHD17–25Q-GFP was applied between the electrodes. The effective applied stock concentration can be as low as 1.0 μg/μl. (B) 8.3 μl of 0.5–2.5 μg/μl stock was applied to the slice between the electrodes. Optimal applied amount of stock can be as low as 1.0 μl. N = 4 for each data point. Molecular Therapy 2001 3, 113-121DOI: (10.1006/mthe.2000.0235) Copyright © 2001 American Society for Gene Therapy Terms and Conditions

FIG. 4 The influence of charge ratio and concentration on gene transfer by lipotransfection. Three sets of charge ratios (DNA:reagent) are compared to each other (2:1, 1:1, and 1:2) at 1 × and 3× concentrations. The 1:1 1× concentration was 700 μl of growth medium with 10.5 μl of the lipid reagent and 3.5 μg of the plasmid, pHD17–25Q-GFP. To vary the charge ratio, the amount of lipid was altered to the appropriate concentration. The 1:1 charge ratio at 3× concentration was significantly more efficient than the other categories. Data points are composed of an average N = 17 with a range from 10 to 25. Molecular Therapy 2001 3, 113-121DOI: (10.1006/mthe.2000.0235) Copyright © 2001 American Society for Gene Therapy Terms and Conditions

FIG. 5 GFP expression after gene transfer by lipotransfection (A, B), electroporation (C, D), and biolistics (E, F). The expression of GFP is seen in cells showing several morphologies, independent of which of the gene transfer methods was used. Purkinje cells (D, F) and Bergman glial cells (C, E) are clearly distinguished by morphology; all three methods transferred genes to these cell types. Pictures of lipotransfected slices (A, B) are included to indicate additional cellular morphologies seen to express GFP using any of the above methods. These pictures are not an exhaustive representation of observed morphologies. The photos were taken from live cultures, except for D, which was fixed in 4% paraformaldehyde. Cell processes can be seen to course in and out of the plane of focus of the slice. The Purkinje cell in D is located near the edge of the slice due to clipping of the folium during processing. Molecular Therapy 2001 3, 113-121DOI: (10.1006/mthe.2000.0235) Copyright © 2001 American Society for Gene Therapy Terms and Conditions